CBIH
Cannabis Bioscience International Holdings, Inc.
Price Chart
Latest Quote
$0.00
+0.00 (+40.00%)
Current Price
| Previous Close | $0.00 |
| Open | $0.00 |
| Day High | $0.00 |
| Day Low | $0.00 |
| Volume | 170,000 |
Stock Information
| Shares Outstanding | 11.63B |
| Total Debt | $1.22M |
| Cash Equivalents | $90 |
| Revenue | $124K |
| Net Income | $-515K |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $4.07M |
| Exchange | OID |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $5.29M |
| Sales | $124K |
| Income | $-515K |
| Cash/sh | $0.00 |
| Employees | 2 |
Financial Ratios
| Quick Ratio | 0.00 |
| Current Ratio | 0.00 |
Returns & Margins
| ROA | -3034.24% |
| Gross Margin | 78.78% |
| Operating Margin | -832.30% |
Ownership
| Insider Ownership | 58.41% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 32.92 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.00 |
| RSI | 54.55 |
| ATR | 0.0001 |
| Shares Float | 4.90B |
| Volatility | 1.50 |
| Rel Volume | 0.63 |
Performance History
| Week | +16.67% |
| Month | +16.67% |
| Quarter | -12.50% |
| 6 Months | -50.00% |
| YTD | -36.36% |
| Year | -30.00% |
| 3 Years | -12.50% |
| 5 Years | -80.56% |
| 10 Years | -99.42% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-16 | $0.00 | 6,804,023 |
| 2026-06-15 | $0.00 | 16,792,526 |
| 2026-06-12 | $0.00 | 4,302,708 |
| 2026-06-11 | $0.00 | 630,000 |
| 2026-06-10 | $0.00 | 2,932,336 |
| 2026-06-09 | $0.00 | 313,502 |
| 2026-06-08 | $0.00 | 4,569,343 |
| 2026-06-05 | $0.00 | 8,537,521 |
| 2026-06-04 | $0.00 | 13,720,200 |
| 2026-06-03 | $0.00 | 8,829,166 |
| 2026-06-02 | $0.00 | 7,014,998 |
| 2026-06-01 | $0.00 | 56,126,768 |
| 2026-05-29 | $0.00 | 78,590,313 |
| 2026-05-28 | $0.00 | 1,561,000 |
| 2026-05-27 | $0.00 | 70,015 |
| 2026-05-26 | $0.00 | 100,000 |
| 2026-05-22 | $0.00 | 1,110,000 |
| 2026-05-21 | $0.00 | 1,112,620 |
| 2026-05-20 | $0.00 | 1,500,000 |
| 2026-05-19 | $0.00 | 0 |
| 2026-05-18 | $0.00 | 125,000 |
About Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. It is also involved in clinical trials and medical research services through its Alpha Research Institute; and sale of CBD products. The company was founded in 2003 and is headquartered in Houston, Texas.
đ° Latest News
No news articles available at the moment. Check back later for updates on CBIH.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $40,106 | $45,599 | $93,450 |
| Cost Of Revenue | $40,106 | $45,599 | $93,450 |
| Total Revenue | $303,022 | $248,841 | $316,825 |
| Operating Revenue | $303,022 | $248,841 | $316,825 |
| Expenses | |||
| Interest Expense | $180,416 | $165,206 | $90,973 |
| Total Expenses | $724,387 | $734,981 | $1,300,196 |
| Rent Expense Supplemental | $65,301 | $86,730 | $71,942 |
| Other Income Expense | $52,961 | - | $41,765 |
| Net Non Operating Interest Income Expense | $-180,416 | $-165,206 | $-90,973 |
| Interest Expense Non Operating | $180,416 | $165,206 | $90,973 |
| Operating Expense | $684,281 | $689,382 | $1,206,746 |
| Other Operating Expenses | $24,517 | $40,065 | $52,352 |
| General And Administrative Expense | $659,764 | $649,317 | $1,154,394 |
| Total Other Finance Cost | - | $11,000 | - |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-548,820 | $-651,345 | $-1,032,579 |
| Net Interest Income | $-180,416 | $-165,206 | $-90,973 |
| Normalized Income | $-601,781 | $-651,345 | $-1,074,344 |
| Net Income From Continuing And Discontinued Operation | $-548,820 | $-651,345 | $-1,032,579 |
| Total Operating Income As Reported | $-421,365 | $-486,140 | $-983,371 |
| Net Income Common Stockholders | $-548,820 | $-651,345 | $-1,032,579 |
| Net Income | $-548,820 | $-651,345 | $-1,032,579 |
| Net Income Including Noncontrolling Interests | $-548,820 | $-651,345 | $-1,032,579 |
| Net Income Continuous Operations | $-548,820 | $-651,346 | $-1,032,579 |
| Pretax Income | $-548,820 | $-651,346 | $-1,032,579 |
| Special Income Charges | $23,638 | $0 | $41,765 |
| Operating Income | $-421,365 | $-486,140 | $-983,371 |
| Gross Profit | $262,916 | $203,242 | $223,375 |
| Per Share | |||
| Diluted EPS | - | $-0.00 | $-0.00 |
| Basic EPS | - | $-0.00 | $-0.00 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-388,490 | $-486,140 | $-946,993 |
| Total Unusual Items | $52,961 | $0 | $41,765 |
| Total Unusual Items Excluding Goodwill | $52,961 | $0 | $41,765 |
| Reconciled Depreciation | $32,875 | $-11,750 | $36,378 |
| EBITDA (Bullshit earnings) | $-335,529 | $-486,140 | $-905,228 |
| EBIT | $-368,404 | $-486,140 | $-941,606 |
| Diluted NI Availto Com Stockholders | $-548,820 | $-651,345 | $-1,032,579 |
| Other Special Charges | $-23,638 | - | $-41,765 |
| Gain On Sale Of Security | $29,323 | - | - |
| Selling General And Administration | $659,764 | $649,317 | $1,154,394 |
| Other Gand A | $419,043 | $356,603 | $422,801 |
| Rent And Landing Fees | $65,301 | $86,730 | $71,942 |
| Salaries And Wages | $175,420 | $205,984 | $659,651 |
| Diluted Average Shares | - | $10,317,612,225 | $9,001,539,324 |
| Basic Average Shares | - | $10,317,612,225 | $9,001,539,324 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-1,163,583 | $-1,079,013 | $-591,665 |
| Total Assets | $31,880 | $57,162 | $43,382 |
| Total Non Current Assets | $2,795 | $35,670 | $23,920 |
| Current Assets | $29,085 | $21,492 | $19,462 |
| Other Current Assets | $598 | $598 | $598 |
| Receivables | $15,535 | $20,139 | $9,951 |
| Accounts Receivable | $6,380 | $20,139 | $9,951 |
| Cash Cash Equivalents And Short Term Investments | $12,952 | $755 | $8,913 |
| Cash And Cash Equivalents | $12,952 | $755 | $8,913 |
| Debt | |||
| Net Debt | $402,371 | $424,492 | $376,586 |
| Total Debt | $420,229 | $452,030 | $389,934 |
| Long Term Debt And Capital Lease Obligation | $249,500 | $254,267 | $249,500 |
| Long Term Debt | $249,500 | $249,361 | $249,500 |
| Current Debt And Capital Lease Obligation | $170,729 | $197,763 | $140,434 |
| Current Debt | $165,823 | $175,886 | $135,999 |
| Other Current Borrowings | $135,496 | $143,248 | $135,999 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $1,195,463 | $1,136,175 | $635,047 |
| Total Non Current Liabilities Net Minority Interest | $249,500 | $254,266 | $249,500 |
| Current Liabilities | $945,963 | $881,909 | $385,547 |
| Other Current Liabilities | $29,322 | $1 | - |
| Payables And Accrued Expenses | $745,912 | $684,145 | $216,472 |
| Interest Payable | $22,095 | - | - |
| Payables | $723,817 | $684,145 | $216,472 |
| Accounts Payable | $100,343 | $165,858 | $111,299 |
| Other Non Current Liabilities | - | $-1 | - |
| Current Deferred Liabilities | - | $0 | $28,641 |
| Equity | |||
| Common Stock Equity | $-1,163,583 | $-1,079,013 | $-591,665 |
| Total Equity Gross Minority Interest | $-1,163,583 | $-1,079,013 | $-591,665 |
| Stockholders Equity | $-1,163,583 | $-1,079,013 | $-591,665 |
| Retained Earnings | $-5,882,901 | $-5,334,081 | $-4,682,736 |
| Other | |||
| Ordinary Shares Number | $11,626,749,347 | $10,431,749,347 | $10,059,677,919 |
| Share Issued | $11,626,749,347 | $10,431,749,347 | $10,059,677,919 |
| Tangible Book Value | $-1,163,583 | $-1,079,013 | $-591,665 |
| Invested Capital | $-748,260 | $-653,766 | $-206,166 |
| Working Capital | $-916,878 | $-860,417 | $-366,085 |
| Capital Lease Obligations | $4,906 | $26,783 | $4,435 |
| Total Capitalization | $-914,083 | $-829,652 | $-342,165 |
| Additional Paid In Capital | $4,719,318 | $4,255,068 | $4,091,071 |
| Capital Stock | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $4,906 | $0 |
| Current Capital Lease Obligation | $4,906 | $21,877 | $4,435 |
| Line Of Credit | $30,327 | $32,638 | $0 |
| Current Accrued Expenses | $22,095 | - | - |
| Dueto Related Parties Current | $623,474 | $518,287 | $105,173 |
| Net PPE | $2,795 | $35,670 | $23,920 |
| Accumulated Depreciation | $0 | $-7,480 | $-131,467 |
| Gross PPE | $2,795 | $43,150 | $155,387 |
| Leases | $2,795 | $43,150 | $155,387 |
| Properties | $0 | $0 | $0 |
| Duefrom Related Parties Current | $9,155 | $0 | - |
| Current Deferred Revenue | - | $0 | $28,641 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-329,627 | $-479,382 | $-898,367 |
| Operating Activities | |||
| Operating Cash Flow | $-329,627 | $-479,382 | $-898,367 |
| Cash Flow From Continuing Operating Activities | $-329,627 | $-479,382 | $-898,367 |
| Financing Activities | |||
| Issuance Of Capital Stock | $244,250 | $70,000 | $801,966 |
| Financing Cash Flow | $341,824 | $471,224 | $875,298 |
| Cash Flow From Continuing Financing Activities | $341,824 | $471,224 | $875,298 |
| Net Common Stock Issuance | $244,250 | $70,000 | $801,966 |
| Common Stock Issuance | $244,250 | $70,000 | $801,966 |
| Other | |||
| Repayment Of Debt | $0 | $-26,677 | $0 |
| Issuance Of Debt | $122,046 | $398,041 | $73,332 |
| Interest Paid Supplemental Data | $136,262 | $93,472 | $93,472 |
| End Cash Position | $12,952 | $755 | $8,913 |
| Beginning Cash Position | $755 | $8,913 | $31,982 |
| Changes In Cash | $12,197 | $-8,158 | $-23,069 |
| Net Issuance Payments Of Debt | $97,574 | $401,224 | $73,332 |
| Net Short Term Debt Issuance | $-24,472 | $29,860 | $73,332 |
| Net Long Term Debt Issuance | $122,046 | $371,364 | $0 |
| Long Term Debt Payments | $0 | $-26,677 | $0 |
| Long Term Debt Issuance | $122,046 | $398,041 | $0 |
| Change In Working Capital | $-63,004 | $70,716 | $170,923 |
| Change In Other Current Liabilities | $-24,285 | $24,756 | $0 |
| Change In Payables And Accrued Expense | $-43,323 | $84,789 | $57,882 |
| Change In Accrued Expense | $22,192 | $0 | $14,793 |
| Change In Interest Payable | $22,095 | $0 | $14,793 |
| Change In Payable | $-65,515 | $84,789 | $43,089 |
| Change In Account Payable | $-65,515 | $84,789 | $43,089 |
| Change In Receivables | $4,604 | $-10,188 | $-4,935 |
| Changes In Account Receivables | $13,759 | $-10,188 | $-4,935 |
| Other Non Cash Items | $220,000 | $112,997 | $-85,089 |
| Unrealized Gain Loss On Investment Securities | $29,322 | $0 | - |
| Depreciation Amortization Depletion | $32,875 | $-11,750 | $36,378 |
| Depreciation And Amortization | $32,875 | $-11,750 | $36,378 |
| Depreciation | $32,875 | $-11,750 | $36,378 |
| Net Income From Continuing Operations | $-548,820 | $-651,345 | $-1,032,579 |
| Short Term Debt Payments | - | $-7,538 | $0 |
| Short Term Debt Issuance | - | $29,860 | $73,332 |
| Change In Other Working Capital | - | $-28,641 | $18,961 |
| Change In Prepaid Assets | - | $0 | $99,015 |
| Stock Based Compensation | - | $0 | $12,000 |
Fetched: 2026-02-02